1. Home
  2. RFL vs GRF Comparison

RFL vs GRF Comparison

Compare RFL & GRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • GRF
  • Stock Information
  • Founded
  • RFL 2017
  • GRF 1989
  • Country
  • RFL United States
  • GRF United States
  • Employees
  • RFL N/A
  • GRF N/A
  • Industry
  • RFL Real Estate
  • GRF Finance/Investors Services
  • Sector
  • RFL Finance
  • GRF Finance
  • Exchange
  • RFL Nasdaq
  • GRF Nasdaq
  • Market Cap
  • RFL 67.7M
  • GRF 39.3M
  • IPO Year
  • RFL N/A
  • GRF N/A
  • Fundamental
  • Price
  • RFL $2.21
  • GRF $10.00
  • Analyst Decision
  • RFL
  • GRF
  • Analyst Count
  • RFL 0
  • GRF 0
  • Target Price
  • RFL N/A
  • GRF N/A
  • AVG Volume (30 Days)
  • RFL 298.0K
  • GRF 3.0K
  • Earning Date
  • RFL 06-11-2025
  • GRF 01-01-0001
  • Dividend Yield
  • RFL N/A
  • GRF 3.70%
  • EPS Growth
  • RFL N/A
  • GRF N/A
  • EPS
  • RFL N/A
  • GRF 1.16
  • Revenue
  • RFL $732,000.00
  • GRF N/A
  • Revenue This Year
  • RFL N/A
  • GRF N/A
  • Revenue Next Year
  • RFL N/A
  • GRF N/A
  • P/E Ratio
  • RFL N/A
  • GRF $8.15
  • Revenue Growth
  • RFL 35.56
  • GRF N/A
  • 52 Week Low
  • RFL $1.28
  • GRF $7.93
  • 52 Week High
  • RFL $3.19
  • GRF $10.19
  • Technical
  • Relative Strength Index (RSI)
  • RFL 62.19
  • GRF 59.48
  • Support Level
  • RFL $1.83
  • GRF $9.86
  • Resistance Level
  • RFL $2.65
  • GRF $10.13
  • Average True Range (ATR)
  • RFL 0.18
  • GRF 0.09
  • MACD
  • RFL 0.04
  • GRF 0.02
  • Stochastic Oscillator
  • RFL 59.69
  • GRF 79.37

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About GRF Eagle Capital Growth Fund Inc.

Eagle Capital Growth Fund Inc is a diversified closed-end investment company. The fund's objective is long-term growth utilizing the concept of total return for selecting investments. It seeks to achieve its investment objectives by investing predominantly in U.S. issuer common stock by giving preference to high-quality companies, where high quality denotes substantial operating income margins, high returns on capital, and robust balance sheets.

Share on Social Networks: